BRCA1 and BRCA2 Gene Mutations of Familial Breast Cancer and Early-Onset Breast Cancer from Hunan Province in China

黄隽,唐利立,胡震,夏婷,饶南燕,邵志敏

DOI: https://doi.org/10.3969/j.issn.1007-3639.2008.08.002

2008-01-01

Abstract:Background and purpose:BRCA1 and BRCA2 gene are known as breast cancer susceptibility genes. Both of them are closely associated with familial breast cancer and early onset breast cancer. The objective of our research is to investigate the prevalence of BRCA1 and BRCA2 gene mutations among Hunan patients with familial or at early onset breast cancer. Methods:50 breast cancer patients with familial history or have suffered from breast cancer at the age of less than 35 years old were analyzed, among whom 26 of the patients(52%) had at least one relative affected. A comprehensive BRCA1 and BRCA2 mutation analysis was performed through denaturing high- performance liquid chromatography (DHPLC) and subsequent DNA direct sequencing. Results:Five mutations were identified that included 2 novel mutations (nonsense mutation 2372CG and frameshift mutation 2808delACAA in BRCA2 gene) and 3 previously reported mutations (nonsense mutation 220CT in BRCA1 gene, frameshift mutations 1796delTTTAT and 6275delTT in BRCA2 gene). Additional 4 variants of unknown and 11 gene polymorphisms were detected. The mutation frequency of BRCA1 and BRCA2 in patients with breast cancer family history was 4% and 16%, respectively. Conclusion:The BRCA2 may contribute to mutation more than BRCA1 in familial breast cancer of Hunan population. Two novel mutations in BRCA2 may be mutations characterized to familial breast cancer of Chinese Hunan population. The mutation frequency of BRCA1 in familial breast cancer patients from Hunan is obviously lower than the western country and the other province of China. However, the mutation frequency of BRCA2 in the Hunan population is similar to the western country but much higher than the other province of China. That is probably the characteristic of BRCA mutation in Hunan population.